Delivery Order SPE2DB22D1017-SPE2DB25FYPPD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Azathioprine 50 mg tablets (100-count units) with a ceiling value of $2,693.60. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,903.50 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units). This contract was competitively awarded without any set-aside designation and is structured as a firm fixed-price delivery order with an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100 count) with a ceiling value of $4,162.09. This firm fixed-price, non-set-aside delivery order was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) under a firm fixed price contract with a ceiling value of $3,600.48. This non-set-aside, competitively awarded delivery order is set for ultimate completion on August 11, 2025, and represents a continuation of the company's pharmaceutical supply support to federal healthcare systems. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,278.02 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100 count) on September 17, 2025, with a completion date of September 18, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Azathioprine 50 mg tablets (100-count units) valued at $2,679.17. This is a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and no set-aside designation was used. The award represents a competitive procurement from AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global...
- The Defense Logistics Agency awarded a $13,018.60 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units. This is a firm fixed price contract with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,187.99 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,672.82 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Azathioprine 50 mg on September 19, 2025, with completion targeted for September 22, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 through December 2026. The pharmaceutical will be supplied...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Azathioprine 50 mg tablets (100 count) with a ceiling value of $3,000.45. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPPDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,194.11 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100 count) with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, awarded on August 29, 2025, represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company has demonstrated extensive capability in fulfilling federal pharmaceutical supply requirements through its established delivery order portfolio with the DLA, which includes diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, vaccines, and specialized medical supplies. This particular delivery order for Azathioprine—an immunosuppressant medication—reflects the company's role in supporting the military's medical supply chain and the broader federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/29/25 |